Ensho Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $7.28M (Form D filed Oct 15, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0002032849-26-000002 (Oct 15, 2026)
  Evidence (2 events)

  • Oct 15, 2026 · SEC Form D 0002032849-26-000002
    Name of Issuer: Ensho Therapeutics, Inc.; CIK: 2032849; Address: Woodcliff Lake, NJ; Submission type: D; Filing date: 2026-10-15; Industry Group: Biotechnology; Date of First Sale: 2026-10-02; Types of Securities Offered: Equity, Security to be acquired; Business combination transaction: false; Total Offering Amount: 15604179; Total Amount Sold: 7281948; Federal exemptions: 06b
  • Feb 9, 2026 · SEC Form D 0002032849-26-000001
    Name of Issuer: Ensho Therapeutics, Inc.; CIK: 2032849; Address: Woodcliff Lake, NJ; Submission type: D; Filing date: 2026-02-09; Industry Group: Biotechnology; Date of First Sale: 2026-01-20; Types of Securities Offered: Equity, Security to be acquired; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 0; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals